Sharon M Leadbitter NSW State Cancer Conference 2023

Sharon M Leadbitter

Sharon is a market access and health policy specialist with over 20 years biopharmaceutical company experience. She managed the first simultaneous reimbursement of drug (Gefitinib, Iressa) on the PBS plus test (EGFR) on the MBS while working at AstraZeneca. TACS Healthcare is an independent consultancy delivering regulatory, reimbursement, product development, market research and health policy strategy and services to biopharmaceutical clients.